Physician profile
Katrina Pyle
NPI 1295284032
$12,679.54
in general payments reported to CMS, 2019-2025
26 companies · $3,978 in 2025
The $3,978 reported for 2025 was more than what 98% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $197 · 2022: $1,167 · 2023: $3,950 · 2024: $3,387 · 2025: $3,978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,172.49 |
| Education | $142.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,345.55 | 2021-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $1,620.20 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,039.11 | 2021-2025 | Ofev, Jascayd, Spiriva Respimat |
| Genzyme Corporation | $866.70 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $706.32 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $692.67 | 2022-2024 | Yupelri |
| Insmed, INC. | $472.38 | 2023-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $454.62 | 2022-2025 | Tyvaso, Tyvaso |
| Baxter Healthcare | $427.78 | 2022-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System, Hillrom - Visivest Airway Clearance System |
| Amgen INC. | $411.70 | 2023-2025 | Tezspire |
| Harmony Biosciences LLC | $394.06 | 2022-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $383.47 | 2023-2025 | |
| Verona Pharma, INC. | $361.57 | 2025 | Ohtuvayre |
| Actelion Pharmaceuticals US, INC. | $314.62 | 2022-2025 | Opsumit, Opsynvi |
| Viatris Specialty LLC | $182.01 | 2025 | Yupelri |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $159.73 | 2024-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Sanofi-Aventis U.S. LLC | $146.99 | 2023-2025 | |
| Inogen, INC. | $135.11 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Philips North America LLC | $133.66 | 2022-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Merck Sharp & Dohme LLC | $131.17 | 2023-2025 | Winrevair, Keytruda |
| Axsome Therapeutics, INC. | $111.25 | 2024-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $72.02 | 2024-2025 | Glassia |
| Lilly USA, LLC | $54.24 | 2025 | Zepbound |
| Edwards Lifesciences Corporation | $24.78 | 2022 | |
| Genentech USA, INC. | $20.97 | 2021 | |
| Inspire Medical Systems, INC. | $16.86 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Pyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.